Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study on Extreme Hypofractionation for Localized Prostate Cancer

NCT05344235 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.

NCT NCT05344235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05344235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study on Extreme Hypofractionation for Localized Prostate Cancer
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Phase
Observational
Overall status
Recruiting
Start date
April 25, 2022
Completion date
April 30, 2032
Enrollment
246 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, radiotherapy, sbrt